Grayslake, IL, United States of America

Westin H Morrill

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Westin H Morrill: Innovator in Pharmaceutical Chemistry

Introduction

Westin H Morrill is a notable inventor based in Grayslake, IL (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of four patents, showcasing his innovative approach to developing new compounds and methods in the field.

Latest Patents

Among his latest patents is a synthetic route to anti-viral agents. This invention provides methods for synthesizing a viral protease inhibitor in high yield, without the need for expensive catalysts or challenging reaction conditions. Another significant patent involves the crystalline form of nicotinamide riboside. This patent includes a Form I of nicotinamide riboside chloride and discloses pharmaceutical compositions comprising this crystalline form. The methods of producing such pharmaceutical compositions and administering the crystalline Form I to subjects are also detailed in this patent.

Career Highlights

Westin H Morrill has worked with prominent companies in the pharmaceutical industry, including AbbVie Inc. and W.R. Grace & Co. His experience in these organizations has contributed to his expertise and success as an inventor.

Collaborations

Throughout his career, Morrill has collaborated with notable professionals, including Russell Drew Cink and Kirill A Lukin. These collaborations have likely enriched his work and led to further advancements in his field.

Conclusion

Westin H Morrill's innovative contributions to pharmaceutical chemistry, particularly in the development of anti-viral agents and nicotinamide riboside, highlight his significant role as an inventor. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…